November 12th 2024
The FDA cleared Novavax to start enrolling the planned phase 3 trial after a safety concern was found to be unrelated to the combination vaccine.
November 11th 2024
Insights on how to manage the "triple threat" of flu, RSV, and COVID-19 this season.
October 7th 2024
Less than one-quarter of people infected with influenza-associated severe acute respiratory illness were vaccinated, according to a new report.
September 30th 2024
Your daily dose of the clinical news you may have missed.
September 20th 2024
FluMist is the first influenza vaccine that does not have to be given by a health care professional.
COVID-19 Vaccine Status Update: Adults, Bivalent Boosters, Kids, & Teens
The overall US COVID-19 vaccination picture has both bright spots and dark areas. Get a quick look at details from the most recent KFF Vaccine Monitor survey.
High-dose Influenza Vaccine Consistently More Effective vs Standard-dose in Older Adults: Meta-analysis
The high-dose influenza vaccines provided greater relative vaccine effectiveness/efficacy vs standard dose in a cohort of more than 45 million.
Primary Care is the Likely "Home" for Long COVID Care: A Conversation with AAFP Board Chair Sterling Ransone, Jr, MD
AAFP Board Chair Ransone points to recent data that show two-thirds of long COVID patients are already treated in primary care settings.
We Can't Predict a COVID-19 Surge, But We Can Prepare Patients for It: AAFP Board Chair Dr Sterling Ransone, Jr
It is clear that COVID-19 comes in waves, but it's too soon in the life of the virus to predict patterns, Ransone says. Strategy? Get shots in arms.
Will This be the Year of the Twindemic? AAFP Board Chair Ransone Thinks Out Loud with Patient Care
About half of American adults plan not to get a flu shot this year; everyone is tired of COVID talk and prevention; but flu is brewing in the southern hemisphere, Ransone says.
The Daily Dose: Adult RSV Vaccine
Your daily dose of clinical news from Patient Care Online.
COVID-19 Vaccines, Boosters, Prior Infection Significantly Reduce Risks, but Immunity Wanes
A large cohort study confirms the observed efficacy of initial and follow-up COVID-19 vaccination and prior infection against infection, hospitalization, and death.
Are the Southern Hemisphere's High Influenza Rates a Warning for the North This Year?
Influenza rates were higher in Australia during the April-October season this year than they have been in 5 years. Should we be preparing now?
Persistent COVID-19 Vaccine Myths Hamper Immunization for Children
Refractory adult misbeliefs about vaccine safety have increased reluctance to vaccinate US children aged 5-11 years, according to an Annenberg Public Policy center survey.
COVID-19 Update: US Vaccinations, Booster Doses, & Global Data as of September 23, 2022
Data from the CDC on US vaccination and booster shot rates and from the Johns Hopkins COVID-19 interactive map on cases and deaths in the US and worldwide.
COVID-19 Update: US Vaccinations, Booster Doses, & Global Data as of September 21, 2022
COVID-19 Update: US Vaccinations, Booster Doses, & Global Data as of September 20, 2022
COVID-19 Update: US Vaccinations, Booster Doses, & Global Data as of September 19, 2022
COVID-19 Update: US Vaccinations, Booster Doses, & Global Data as of September 16, 2022
COVID-19 Update: US Vaccinations, Booster Doses, & Global Data as of September 15, 2022
COVID-19 Update: US Vaccinations, Booster Doses, & Global Data as of September 13, 2022
COVID-19 Update: US Vaccinations, Booster Doses, & Global Data as of September 12, 2022
COVID-19 Update: US Vaccinations, Booster Doses, & Global Data as of September 9, 2022
COVID-19 Bivalent Booster Shot Q&A for Clinicians
Get answers to 7 questions you may have regarding bivalent booster dose vaccination for patients from the US Centers for Disease Control and Prevention.
COVID-19 Update: US Vaccinations, Booster Doses, & Global Data as of September 8, 2022
COVID-19 Update: US Vaccinations, Booster Doses, & Global Data as of September 7, 2022
COVID-19 Update: US Vaccinations, Booster Doses, & Global Data as of September 6, 2022
COVID-19 Update: US Vaccinations, Booster Doses, & Global Data as of September 2, 2022
COVID-19 Update: US Vaccinations, Booster Doses, & Global Data as of August 31, 2022
FDA Authorizes Pfizer and Moderna Updated COVID-19 Booster Shots
The FDA EUA amendments for updated booster vaccinations are based on clinical studies of the omicron BA.1 variant and preclinical data on the BA.4 and BA.5 variants.
The Future of US Antimicrobial Resistance is in Our Hands and There is Work to Do
Steer clear of antibiotic Rxs whenever possible, says Anne Meneghetti, MD, to help the US get back to pre-COVID levels of antimicrobial stewardship.
COVID-19 Update: US Vaccinations, Booster Doses, & Global Data as of August 30, 2022
Primary Care Can Help Restore US Antibiotic Stewardship, Starting with Flu Shots
Preventing viral infections with vaccination can keep the most vulnerable out of the hospital, reducing the risk of bacterial superinfections.
COVID-19 Update: US Vaccinations, Booster Doses, & Global Data as of August 29, 2022
Superinfection Rate in Hospitalized COVID-19 Patients was Found to be Low
Only 9% of inpatients with COVID-19 had a bacterial superinfection that could be treated with antibiotics which curbed use of broad-spectrum antimicrobials.